Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,914 | 473 | 926 | 1,715 | 5,269 |
| Receivables | 1,089 | 373 | 275 | 297 | 263 |
| Inventories | 547 | 177 | 197 | 273 | 350 |
| TOTAL | $5,566 | $1,041 | $1,456 | $2,459 | $6,142 |
| Non-Current Assets | |||||
| PPE Net | 316 | 362 | 461 | 548 | 440 |
| Intangibles | 441 | 529 | 658 | 822 | 980 |
| TOTAL | $757 | $891 | $1,119 | $1,370 | $1,420 |
| Total Assets | $6,323 | $1,932 | $2,575 | $3,829 | $7,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,344 | 553 | 608 | 426 | 479 |
| Accrued Expenses | 168 | 185 | 170 | 249 | 216 |
| Other current liabilities | N/A | N/A | N/A | 1,853 | 1,841 |
| TOTAL | $1,512 | $738 | $1,281 | $2,528 | $2,536 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $4 | $13 | $11 | $3 |
| Total Liabilities | $1,512 | $742 | $1,294 | $2,539 | $2,539 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,073 | 79,994 | 71,582 | 67,932 | 64,824 |
| Common Shares | 871 | 768 | 683 | 631 | 649 |
| Retained earnings | -123,474 | -123,478 | -116,924 | -109,482 | -103,219 |
| TOTAL | $4,811 | $1,190 | $1,281 | $1,290 | $5,023 |
| Total Liabilities And Equity | $6,323 | $1,932 | $2,575 | $3,829 | $7,562 |